Zithromax, Azithromycin Newswire (Page 7)

Zithromax, Azithromycin Newswire (Page 7)

Comprehensive Real-Time News Feed for Zithromax, Azithromycin (generic). (Page 7)

Results 121 - 140 of 914 in Zithromax, Azithromycin (generic)

  1. U.S. cases of drug-resistant gonorrhea rise fourfold in one yearRead the original story w/Photo

    Jul 14, 2016 | UPI

    This new data, from the U.S. Centers for Disease Control and Prevention, should serve as a warning that "the future of current treatment options may be in jeopardy," the agency said in a news release issued Thursday. "The confluence of emerging drug resistance and very limited alternative options for treatment creates a perfect storm for future gonorrhea treatment failure in the U.S.," said Dr. Jonathan Mermin, who directs the CDC's National Center for HIV /AIDS, Viral Hepatitis, STD, and Tuberculosis Prevention.


  2. The shocking way you can catch chlamydia WITHOUT having sex STIS are...Read the original story w/Photo

    Jul 6, 2016 | Daily Star

    You probably don't believe that you could have a sexually-transmitted infection and not know about it, but most people don't know they have chlamydia. It's the most common STI in the UK and across the world the disease has infected approximately 141million people.


  3. Ded Symptom SolutionsRead the original story w/Photo

    Jul 5, 2016 | Optometric Management

    HE DIAGNOSIS of dry eye disease elicits a myriad of emotions in patients. For example, a poll of 776 DED sufferers reveals that nine in 10 consider their symptoms to be bothersome, according to a 2015 Gallup Study of Dry Eye Sufferers.


  4. Beware the Maga Clap: Brits sick with STIs at party paradise MagalufRead the original story w/Photo

    Jul 4, 2016 | Daily Star

    Young tourists at the clubbing hotspot are saying there has been an outbreak of Chlamydia that is spreading quickly among randy Brits. The illness is usually symptomless, but can cause discharge and bleeding from the genitalia, as well as long-term problems like swollen testicles, pelvis disease and infertility.


  5. Prevalence and correlates of Mycoplasma genitalium infection among...Read the original story

    Jul 4, 2016 | CSIRO Publishing

    Xiaohui Mo A C , Caixia Zhu A , Jin Gan A , Chong Wang A , Fang Wei B , Weiming Gong D E and Qiliang Cai A E A Key Laboratory of Medical Molecular Virology , Department of Etiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China. B ShengYushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.


  6. Diagnosis and treatment of urethritis in men.Read the original story

    Jun 25, 2016 | CiteULike

    Symptoms of urethritis in men typically include urethral discharge, penile itching or tingling, and dysuria. A diagnosis can be made if at least one of the following is present: discharge, a positive result on a leukocyte esterase test in first-void urine, or at least 10 white blood cells per high-power field in urine sediment.


  7. Management of non-gonococcal urethritis.Read the original story

    Jun 25, 2016 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Non-gonococcal urethritis , or inflammation of the urethra, is the most common treatable sexually transmitted syndrome in men, with approximately 20-50 % of cases being due to infection with Chlamydia trachomatis and 10-30 % Mycoplasma genitalium.


  8. U.K. Case of Throat Gonorrhea Resists AntibioticsRead the original story w/Photo

    Jun 23, 2016 | MedlinePlus

    In an alarming development, British public health experts have confirmed a case of throat gonorrhea that proved untreatable with the standard antibiotic regimen. The patient, a heterosexual man who had just returned to the United Kingdom from Japan, wasn't cured by a pair of antibiotics used as the first-line gonorrhea treatment in many countries, including the United States.


  9. How gonorrhea is becoming untreatable: Doctors feared man who had...Read the original story w/Photo

    Jun 24, 2016 | Daily Mail

    Health experts fear the disease is hurtling towards becoming untreatable with increasing numbers of cases where patients fail to respond to antibiotics. The patient, a heterosexual man who had just returned to the UK from Japan, was treated using a combination of antibiotics.


  10. Failure of dual antimicrobial therapy for gonorrhea reportedRead the original story w/Photo

    Jun 23, 2016 | PhysOrg Weblog

    In a case report published in the June 23 issue of the New England Journal of Medicine , dual antimicrobial therapy failure is described in the treatment of gonorrhea. Helen Fifer, B.M.B.S., from Public Health England in London, and colleagues describe treatment failure with dual therapy in a heterosexual man with gonorrhea .


  11. SpeeDx Announces Results Of M. genitalium ResistancePlus StudyRead the original story

    Jun 22, 2016 | BioSpace

    Ltd. announced that a study using a beta version of PlexPCR M. genitalium ResistancePlus shows strong results in the detection of both M. genitalium and mutations in the 23S rRNA gene of the bacteria that have been shown to confer resistance to commonly prescribed macrolide based antibiotics. The study, Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance using PlexZyme and PlexPrime Technology , published in PLOS ONE , was performed in collaboration with "We believe this study is a positive first step in combatting the growing problem of antibiotic resistance in M. genitalium ," said Prof.


  12. Spero Unveils Data On Lead Potentiator Candidate For The Treatment Of ...Read the original story

    Jun 20, 2016 | BioSpace

    The data were presented at the first annual ASM Microbe 2016 conference in Novel approaches to the treatment of multidrug resistant Gram-negative bacterial infections are urgently required. Current treatment options are limited to drugs that are only modestly effective or are highly toxic at effective doses.


  13. Bacterial Conjunctivitis Drugs Market - Fluoroquinolones to Be the Largest Segment by 2024Read the original story w/Photo

    Jun 20, 2016 | SBWire

    Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. The majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity.


  14. Nabriva Presents Data on Lefamulin at the American Society of...Read the original story

    Jun 20, 2016 | P&T Community

    VIENNA, Austria, and KING OF PRUSSIA, Pa., June 20, 2016 -- Nabriva Therapeutics AG , a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics, announced today research findings for lefamulin, the Company's lead product candidate. Lefamulin is a novel semi-synthetic antibiotic Nabriva is developing to be the first pleuromutilin antibiotic available for systemic administration in humans and is the first new class of antibiotic to have reached late stage clinical development for Community Acquired Bacterial Pneumonia in over a decade.


  15. Campylobacter jejuni-associated perimyocarditis: two case reports and review of the literatureRead the original story w/Photo

    Jun 13, 2016 | BioMed Central

    Campylobacter spp. are among the most common bacterial causes of gastroenteritis world-wide and mostly follow a benign course.


  16. At Least 75% Of Patients Who Test Negative For Gonorrhea, Chlamydia...Read the original story w/Photo

    Jun 8, 2016 | Medical Daily

    Gonorrhea and Chlamydia are two sexually transmitted diseases that can be treated with antibiotics either orally or by injection. Obviously treatment should only be administered if tests show patients have one of these diseases or if they have been exposed to them, but new research published in the American Journal of Infection Control found that more than 75 percent of patients treated with these antibiotics actually tested negative for these diseases.


  17. Urinary Antibacterial and Antiseptic Pharmaceuticals Market 10-Year ForecastRead the original story w/Photo

    Jun 7, 2016 | PR Log

    FMI's New Report, titled, "Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2016-2026" offers 10-year forecast and analysis. VALLEY COTTAGE, N.Y. - June 7, 2016 - PRLog -- Urinary tract infection refers to bacterial infection in any part of urinary system such as urethra, ureters, bladder and kidney.


  18. Take charge of your sex lifeRead the original story w/Photo

    Jun 4, 2016 | The Star Online

    The word appeared from about 200 BC and was assumed to make revelation of the ultimate divine purpose, especially concerning a cataclysm in which the forces of good triumph over evil. It is suppose to represent any revelation or prophecy.


  19. North East one of the most at-risk areas of a 'super-gonorrhoea' outbreak in whole of UKRead the original story w/Photo

    Jun 4, 2016 | Chronicle Live

    These two drugs are among the last antibiotics that get rid of the bacteria because it has developed resistance to others. But Public Health England warned in April of a strain of the sexually transmitted infection that is highly resistant to azithromycin centred in Leeds.


  20. Another Gem In The Novel Broad Spectrum Antibiotic Race: Nabriva TherapeuticsRead the original story w/Photo

    Jun 3, 2016 | Seeking Alpha

    We are initiating coverage on the American Depositary Share for Nabriva Therapeutics with a Buy rating and price target of $19.48 per ADS. Our valuation is based on the enterprise DCF model with forecasts of U.S. $540 million and EU $1.08 billion risk-adjusted, peak lefamulin sales .